Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell LymphomaMark W. Clemens, Roberto N. Miranda, Vinita Parkash et al.|Journal of Clinical Oncology|2015Cited by 418
Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experienceYasuhiro Oki, Jason R. Westin, Mansoor Noorani et al.|British Journal of Haematology|2014Cited by 364
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trialNathan Fowler, Sattva S. Neelapu, R. Eric Davis et al.|The Lancet Oncology|2014Cited by 263
The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphomaDai Chihara, Yasuhiro Oki, Michelle A. Fanale et al.|British Journal of Haematology|2016Cited by 118
Prognostic Factors of Hepatosplenic T-cell LymphomaMariko Yabe, Roberto N. Miranda, L. Jeffrey Medeiros et al.|The American Journal of Surgical Pathology|2016Cited by 82